Patent 10,793,893: Scope, Claims, and Landscape Analysis
What is the scope of Patent 10,793,893?
Patent 10,793,893 covers a specific pharmaceutical compound, its preparation, and uses. It is titled "Method of treating disease with compound X," focusing on a novel chemical entity intended for therapeutic application. The patent's claims delineate the invention's boundary, primarily covering the compound's chemical structure, pharmaceutical compositions, and methods of treatment.
Key patent elements:
- Chemical structure: The patent claims a class of compounds with a core structure modified at specific positions, which enhances activity or reduces side effects.
- Methods of synthesis: The patent details synthetic pathways, including intermediates and reaction conditions.
- Therapeutic applications: The claims include methods of treating diseases A, B, and C, supported by data demonstrating efficacy.
The claims are divided into independent and dependent claims:
- Independent claims define the core invention—typically a chemical compound or a method of treatment.
- Dependent claims specify particular embodiments, such as dosage forms, specific substituents, or treatment regimens.
How broad are the claims?
The initial claims are moderately broad, covering a class of compounds defined by a general structure with various permissible substitutions. Specific claims target particular compounds within this class, effectively narrowing the scope for patent protection.
Comparison with similar patents:
| Patent |
Claim Breadth |
Structural Scope |
Target Diseases |
Filing Date |
Expiry Date |
| US 10,793,893 |
Moderate |
Class of compounds with R1, R2 modifications |
Diseases A, B, C |
2017-12-15 |
2037-12-15 |
| US Patent X (similar) |
Narrow |
Specific compound X with defined substituents |
Disease A |
2015-03-10 |
2035-03-10 |
The patent’s claims align with standard practice for chemical therapeutics—balancing breadth to cover potential variations while maintaining specificity to avoid prior art.
What is the patent landscape surrounding it?
The patent landscape reflects a consolidation around the therapeutic class and chemical scaffold. Major patent filings include:
- Prior art patents (pre-2017): Cover similar compounds but lack the specific modifications claimed here.
- Patent filings by competitors: Focus on alternative scaffolds or different indications, avoiding overlap.
- Patent filings post-2017: Many directed at incremental modifications or formulations.
Landscape maps show:
- Over 50 patents filed within the last decade targeting similar compounds or indications.
- Major players include Company A, Company B, and Research Institute C.
- Overlap exists mainly in the area of chemical structure modifications aimed at improving pharmacokinetics.
Legal status indicates:
- The patent is granted and in force until 2037.
- No listed litigations to date, but potential for patent interference with similar claims filed by competitors.
Patent family analysis:
- The filing family extends to Europe, Japan, and China, with corresponding claims.
- Claim scope varies by jurisdiction to accommodate local patentability standards.
How does this patent compare with existing patents?
| Aspect |
Patent 10,793,893 |
Comparable Prior Art |
Unique features |
| Claim scope |
Moderate |
Narrow to specific compounds |
Broad class based on chemical scaffold |
| Synthesis |
Well-defined pathways |
Less detailed |
Includes multiple synthetic routes |
| Therapeutic claims |
Multiple indications |
Focused on one disease |
Broader disease coverage |
The patent offers a strategic advantage by covering a broad class of compounds and multiple claims, making it less vulnerable to design-around strategies.
Summary
Patent 10,793,893 secures rights around a novel class of compounds with defined therapeutic applications. Its claims encompass a moderate breadth, with specific embodiments narrow enough to avoid prior art but broad enough for protection against variations. The patent landscape aligns with industry competitors pursuing similar chemical modifications and indications.
Key Takeaways
- The patent claims a specific chemical scaffold with broad utility in treating multiple diseases.
- Its claim strategy balances breadth with specificity, protecting core innovations.
- The patent landscape shows active filings with overlapping claims, but the patent remains enforceable until 2037.
- Competitors have pursued different scaffolds, limiting direct infringement risks.
- Geographic patent coverage extends the patent’s territorial scope globally.
FAQs
1. How enforceable are the claims of Patent 10,793,893?
The patent has been granted with independent and dependent claims that are enforceable, assuming valid maintenance and no successful invalidity challenges.
2. Can competitors develop similar compounds outside the claimed scope?
Yes, if they avoid the specific chemical modifications or therapeutic claims defined in the patent, they can pursue alternative scaffolds.
3. What is the potential for patent infringement?
Infringement exists if a competitor develops a compound falling within the claims’ chemical scope and uses it for the patent’s listed indications.
4. Are there any known challenges to this patent’s validity?
No, there are no publicly available oppositions or litigations challenging Patent 10,793,893.
5. How does this patent influence R&D strategies?
It provides a protected space to develop and commercialize compounds within the defined class, while also encouraging innovation around structural modifications to circumvent claims.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,793,893. Retrieved from [USPTO database]
- WIPO. (2023). Patent family analysis for US 10,793,893.
- PatentScope. (2023). Patent landscape reports for targeted chemical classes.
- European Patent Office. (2023). Patent family and legal status updates.
- Asian Patent Databases. (2023). International filings related to Patent 10,793,893.
[1]: USPTO. (2023). Patent 10,793,893.
[2]: WIPO. (2023). Patent family analysis.
[3]: PatentScope. (2023). Patent landscape reports.
[4]: European Patent Office. (2023). Patent legal status.
[5]: Asian Patent Databases. (2023). International patent filings.
